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Introduction
Despite advances in critical care that have improved ICU
outcomes in cirrhotic patients with acute decompensation
they continue to present a high mortality.
Objectives
Our aim was to obtain a mortality prediction model for
patients admitted to the ICU with Acute on Chronic Liver
Failure (ACLF), based on early clinical data.
Methods
Retrospective study performed on patients admitted to our
ICU with ACLF between 2010 and 2013. We collected
epidemiological and clinical data in addition to scoring
systems commonly used in critical care units and those
more specific to cirrhotic patients.
Descriptive data were described as means with standard
deviation for normally distributed continuous variables,
medians with interquartile range (IQR) for non-normally
distributed variables, and percentages for categorical data.
The continuous variables were categorised according to
maximum discrimination point by the area under the
receiver operating characteristic (AUROC) curve.
The variables were compared using the Student t test for
continuous variables, and the Chi-square test for categori-
cal data. The predictive model was obtained by multiple
logistic regression analysis.
Results
Sixty-one patients, 79% male. Age 53 yrs (48 - 61). Charl-
son Comorbidity Index 4 pts (3 - 6). Severity scores:
APACHE II 22 (18 - 25), SOFA 10 pts (8 - 13), MELD 19
pts (14 - 24), CLIF-SOFA 11 pts (9-1 4). 27% of patients
had dysfunction of more than two organs. Alcohol abuse
(55%) was the most frequent cirrhosis etiology and
CHILD C (34%) the most prevalent cirrhosis stage. Reason
for ICU admission: upper gastrointestinal haemorrhage
38%, hepatic encephalopathy 33% and sepsis 23%. 89% of
patients required mechanical ventilation, 77% vasopressor
therapy and 26% renal replacement therapy. Length of
ICU stay 7 days (3-14) and 49.2% mortality in ICU.
In the univariate analysis, the variables related to mor-
tality were: CHILD C stage (RR 4.64; CI 95% 1.47-14.63),
Admission diagnosis Sepsis (RR 3.68; CI 95% 1.01-
13.48), dysfunction of more than two organs (RR 8.37;
CI 95% 2.06-34.03), APACHE II > 22 pts (RR 5.84; CI
95% 1.89-17.99), MELD> 22 pts (RR 7.56; CI 95% 2.16-
26.45), CLIF-SOFA> 12 pts (RR 13.30; CI 95% 3.63-
48.69), vasopressor therapy (RR 2.76; CI 95% 1.90-4.04)
and renal replacement therapy (RR 2.14; CI 95% 1.96-
3.14).
Using multiple logistic regression, we created a model
which included the following variables: Admission diag-
nosis sepsis (OR 5.34; CI 95% 1.04-27.39), dysfunction of
more than two organs (OR 4.50; CI 95% 0.75-26.79),
MELD> 22 pts (OR 5.38; CI 95% 1.16-24.92), APACHE
II >22 pts (OR 5.94; CI 95% 1.36-25.99).
The model obtained had a good discriminatory capacity
for patient prognosis: AUROC 0.85; IC 95% 0.75-0.96
and Hosmer-Lemeshow test; X2 0.59, p = 0.90.
(Figure 1)
Conclusions
In our experience, the predictive model created using clin-
ical variables obtained early on ICU admission was able to
discriminate the prognosis in patients with ACLF.
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